Lupin receives FDA approval for Generic TOBI inhalation solution

Lupin has received final approval for its Tobramycin inhalation solution USP, 300 mg/ 5 ml from the United State Food & Drug Administration to market a generic version of Novartis Pharmaceuticals Corporation’s TOBI 300 mg / 5 ml.

March 23, 2017 / 03:45 PM IST

live

bselive
nselive

Volume

Todays L/H

Lupin Receives FDA Approval for Generic TOBI

Tags: #Announcements

first published: Mar 23, 2017 03:45 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Invest in Commercial Real Estate Fractionally

Expert Trading Guidance

Lupin receives FDA approval for Generic TOBI inhalation solution

Lupin has received final approval for its Tobramycin inhalation solution USP, 300 mg/ 5 ml from the United State Food & Drug Administration to market a generic version of Novartis Pharmaceuticals Corporation’s TOBI 300 mg / 5 ml.